These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30816739)

  • 1. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective.
    Baker DE; Edmonds KA; Calvert ML; Sanders SM; Bridges AJ; Rhea MA; Kosloff S
    Psychol Serv; 2020 Nov; 17(4):472-482. PubMed ID: 30816739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.
    Stahler GJ; Mennis J; DuCette JP
    Addict Behav; 2016 Jul; 58():129-35. PubMed ID: 26925821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient hospitalization for substance use disorders one year after residential rehabilitation: predictors among US veterans.
    Chang G; Martin KB; Tang M; Fleming JA
    Am J Drug Alcohol Abuse; 2016; 42(1):56-62. PubMed ID: 26485005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
    Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
    J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between residential treatment length, PTSD, and outpatient healthcare utilization among veterans.
    Banducci AN; Bonn-Miller MO; Timko C; Rosen CS
    Psychol Serv; 2018 Nov; 15(4):529-535. PubMed ID: 29265844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs.
    Fanucchi LC; Lofwall MR; Nuzzo PA; Walsh SL
    J Subst Abuse Treat; 2018 Sep; 92():64-69. PubMed ID: 30032946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting drop out from, and retention in, specialist drug treatment services: a case control study in the North West of England.
    Beynon CM; McMinn AM; Marr AJ
    BMC Public Health; 2008 May; 8():149. PubMed ID: 18460202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment attrition from couple therapy for male drug abusers.
    Kelly S; Epstein EE; McCrady BS
    Am J Drug Alcohol Abuse; 2004; 30(1):1-19. PubMed ID: 15083551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programme factors that influence completion of residential treatment.
    Meier PS; Best D
    Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment.
    Stein BD; Kogan JN; Sorbero M
    Drug Alcohol Depend; 2009 Sep; 104(1-2):100-6. PubMed ID: 19481884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with substance use treatment completion in residential facilities.
    Mutter R; Ali MM; Smith K; Strashny A
    Drug Alcohol Depend; 2015 Sep; 154():291-5. PubMed ID: 26210736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality disorders and retention in a therapeutic community for substance dependence.
    Samuel DB; LaPaglia DM; Maccarelli LM; Moore BA; Ball SA
    Am J Addict; 2011; 20(6):555-62. PubMed ID: 21999502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.